Dr. Mayuresh Kiran — Author Profile – International Journal of Innovative Research in Medical Science
DM

Dr. Mayuresh Kiran

Research Associate, Pharmacovigilance, Centaur Pharmaceuticals Pvt. Ltd.
13
Publications
1
Journals
2019
Active
Impact & Metrics
15,724
Total Views
5,248
Downloads
0
Citations
13
Publications
Publications 13
1.
Safety and Efficacy of the Combination of Amitriptyline and Pregabalin SR in Severe Neuropathic Pain: Data of Logic Trial
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 81 to 86 Jan 2019 10.23958/ijirms/vol04-i01/557
2.
Safety and Efficacy of the Combination of Amitriptyline and Pregabalin SR in Severe Neuropathic Pain: Data of Logic Trial
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 81 to 86 Jan 2019 10.23958/ijirms/vol04-i01/557
3.
Safety and Efficacy of the Combination of Amitriptyline and Pregabalin SR in Severe Neuropathic Pain: Data of Logic Trial
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 81 to 86 Jan 2019 10.23958/ijirms/vol04-i01/557
4.
A Multi-centered Study to Evaluate the Efficacy and Safety of Amitriptyline and Mecobalamine in the Management of Neuropathic Pain
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 76 to 80 Jan 2019 10.23958/ijirms/vol04-i01/556
5.
A Multi-centered Study to Evaluate the Efficacy and Safety of Amitriptyline and Mecobalamine in the Management of Neuropathic Pain
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 76 to 80 Jan 2019 10.23958/ijirms/vol04-i01/556
6.
A Multi-centered Study to Evaluate the Efficacy and Safety of Amitriptyline and Mecobalamine in the Management of Neuropathic Pain
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 76 to 80 Jan 2019 10.23958/ijirms/vol04-i01/556
7.
Efficacy and Safety of Teneligliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease: ATEND-CKD Study
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 16 to 20 Jan 2019 10.23958/ijirms/vol04-i01/538
8.
Efficacy and Safety of Teneligliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease: ATEND-CKD Study
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 16 to 20 Jan 2019 10.23958/ijirms/vol04-i01/538
9.
Efficacy and Safety of Teneligliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease: ATEND-CKD Study
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 16 to 20 Jan 2019 10.23958/ijirms/vol04-i01/538
10.
Efficacy and Safety of Teneligliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease: ATEND-CKD Study
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 16 to 20 Jan 2019 10.23958/ijirms/vol04-i01/538
11.
Efficacy and Safety for the Combination of Levosalbutamol, Ambroxol and Guaifenesin for the Symptomatic Treatment of Productive Cough: Phase IV Clinical Trial
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 11 to 15 Jan 2019 10.23958/ijirms/vol04-i01/537
12.
Efficacy and Safety for the Combination of Levosalbutamol, Ambroxol and Guaifenesin for the Symptomatic Treatment of Productive Cough: Phase IV Clinical Trial
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 11 to 15 Jan 2019 10.23958/ijirms/vol04-i01/537
13.
Efficacy and Safety for the Combination of Levosalbutamol, Ambroxol and Guaifenesin for the Symptomatic Treatment of Productive Cough: Phase IV Clinical Trial
International Journal of Innovative Research in Medical Science Vol. 4, No. 01 (2019) pp. 11 to 15 Jan 2019 10.23958/ijirms/vol04-i01/537
Author Resources